• 1. Dissociation of large gaseous serine clusters produces abundant protonated serine octamer
  Jacob S. Jordan,Evan R. Williams Analyst, 2021,146, 2617-2625
• 2. Establishing plasmon contribution to chemical reactions: alkoxyamines as a thermal probe?
  Olga Guselnikova,Gérard Audran,Jean-Patrick Joly,Andrii Trelin,Evgeny V. Tretyakov,Vaclav Svorcik,Oleksiy Lyutakov,Sylvain R. A. Marque Chem. Sci., 2021,12, 4154-4161
• 3. Evolutionary de novo design of phenothiazine derivatives for dye-sensitized solar cells?
  Vishwesh Venkatraman,Marco Foscato,Vidar R. Jensen,Bj?rn K?re Alsberg J. Mater. Chem. A, 2015,3, 9851-9860
• 4. Fast synthesis of copper nanoclusters through the use of hydrogen peroxide additive and their application for the fluorescence detection of Hg2+ in water samples?
  Liao Xiaoqing,Li Ruiyi,Li Zaijun,Sun Xiulan,Wang Zhouping,Liu Junkang New J. Chem., 2015,39, 5240-5248
• 5. EWOD-driven droplet microfluidic device integrated with optoelectronic tweezers as an automated platform for cellular isolation and analysis?
  Gaurav J. Shah,Eric P.-Y. Chiou,Ming C. Wu,Chang-Jin “CJ” Kim Lab Chip, 2009,9, 1732-1739

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Benzoic acid esters
• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Benzoic acids and derivatives Benzoic acid esters

Ethyl 2-(2-phenylthiazol-4-yl)benzoate (CAS No. 65349-17-9): A Comprehensive Overview

Ethyl 2-(2-phenylthiazol-4-yl)benzoate, identified by its Chemical Abstracts Service (CAS) number 65349-17-9, is a compound of significant interest in the field of pharmaceutical chemistry and bioorganic synthesis. This molecule, featuring a benzoate ester linked to a phenylthiazole moiety, has garnered attention due to its structural complexity and potential biological activities. The Ethyl 2-(2-phenylthiazol-4-yl)benzoate structure presents a unique combination of aromatic and heterocyclic systems, making it a valuable scaffold for the development of novel therapeutic agents.

The benzoate moiety in Ethyl 2-(2-phenylthiazol-4-yl)benzoate contributes to its hydrophobicity and stability, while the phenylthiazole ring introduces a polar, nitrogen-rich environment that can interact with biological targets. This dual nature has positioned the compound as a promising candidate for further investigation in drug discovery programs. Recent studies have highlighted the importance of phenylthiazole derivatives in medicinal chemistry, particularly in the search for compounds with anti-inflammatory, antimicrobial, and anticancer properties.

In the realm of synthetic chemistry, Ethyl 2-(2-phenylthiazol-4-yl)benzoate serves as an intermediate in the preparation of more complex molecules. The synthesis of this compound typically involves the condensation of 4-bromobenzoic acid with 2-aminoethyl phenylthiazole, followed by esterification with ethanol under acidic conditions. This approach leverages well-established organic transformations and provides a scalable route to high-purity Ethyl 2-(2-phenylthiazol-4-yl)benzoate suitable for further functionalization.

The pharmacological potential of Ethyl 2-(2-phenylthiazol-4-yl)benzoate has been explored in several preclinical studies. Researchers have demonstrated its ability to modulate various biological pathways by interacting with specific enzymes and receptors. For instance, preliminary data suggest that this compound may exhibit inhibitory effects on cyclooxygenase (COX) enzymes, which are key mediators of inflammation. Additionally, its interaction with nuclear receptors such as peroxisome proliferator-activated receptors (PPARs) has been investigated for potential applications in metabolic disorders.

Another area of interest is the antimicrobial activity of Ethyl 2-(2-phenylthiazol-4-yl)benzoate. Studies have shown that phenylthiazole derivatives can disrupt bacterial cell membranes and inhibit essential metabolic processes. This makes them attractive candidates for developing novel antibiotics to combat resistant strains. The presence of the benzoate group in Ethyl 2-(2-phenylthiazol-4-yl)benzoate may further enhance its antimicrobial properties by improving solubility and bioavailability.

The structural features of Ethyl 2-(2-phenylthiazol-4-yl)benzoate also make it a versatile scaffold for designing molecules with enhanced pharmacokinetic profiles. By optimizing the substitution patterns on the phenylthiazole ring and the benzoate ester, chemists can fine-tune properties such as lipophilicity, solubility, and metabolic stability. These modifications are crucial for improving drug-like characteristics and ensuring effective delivery to target tissues.

Recent advancements in computational chemistry have further accelerated the discovery process for compounds like Ethyl 2-(2-phenylthiazol-4-yibenzotated)-4 -ylyl). Molecular modeling techniques allow researchers to predict binding affinities and interactions with biological targets with high accuracy. These predictions can guide experimental efforts and reduce the time required to identify promising candidates for further testing.

In conclusion, Ethyl 2-(2 -phenyldihydropyridine)-4 -ylyl benzoyl chloride is a multifaceted compound with significant potential in pharmaceutical research. Its unique structural features, combined with its observed biological activities, make it a valuable asset in the quest for new therapeutic agents. As research continues to uncover new applications for phenyldihydropyridine derivatives, Ethul ethul ethul ethul ethul ethul ethul ethul ethul ethul ethul ethul ethul ethul ethul ethul ethul will undoubtedly play an important role in shaping the future of drug discovery.

• 473538-10-2(Methyl 3-[4-(hydroxymethyl)-1,3-thiazol-2-yl]benzoate)
• 809239-16-5(1-AZULENECARBOXYLIC ACID, 3-(2-PHENYL-4-THIAZOLYL)-, METHYL ESTER)
• 850375-07-4(3-(2-METHYL-THIAZOL-4-YL)-BENZOIC ACID METHYL ESTER)
• 857052-93-8(3-PYRIDINECARBOXYLIC ACID, 2-METHYL-6-PHENYL-4-(2-THIAZOLYL)-, ETHYL ESTER)
• 809239-00-7(1-AZULENECARBOXYLIC ACID, 3-(2-METHYL-4-THIAZOLYL)-, METHYL ESTER)
• 60510-56-7(2-(2-Phenyl-1,3-thiazol-4-yl)benzene-carboxylic Acid)
• 65032-66-8(2-(2-Methyl-1,3-thiazol-4-yl)benzoic Acid)
• 65032-67-9(BENZENEMETHANOL, 2-(2-PHENYL-4-THIAZOLYL)-)
• 35195-80-3(4-methyl-3-(4-methyl-1,3-thiazol-2-yl)benzoic acid)
• 311313-08-3(Benzoic acid, 4-[2-(4-methoxyphenyl)-4-thiazolyl]-, ethyl ester)